1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Calistoga Pharmaceuticals, Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2006

Location

Seattle WA US

Primary Industry

Healthcare Specialists

About

Calistoga Pharmaceuticals, Inc. is based in Seattle, US and develops innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve the health of patients with cancer and inflammatory diseases.
Current Investors
ICOS Capital, Alta Partners, Frazier Healthcare Partners

Request a demo to show more

Primary Industry
Healthcare Specialists
Sub Industries
Oncology/Cancer Treatment
Website
www.calistogapharma.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.